[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352163-105":59,"doc-detail-352163-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","nuclear-localization-of-the-glutaminyl-trna-synthetase-qars-reveals-its-role-in-dna-damage-response-in-ovarian-cancer-abstract","Nuclear localization of the glutaminyl-tRNA synthetase QARS reveals its role in DNA damage response in ovarian cancer - Abstract","","High-grade serous ovarian cancers (HGSOC) pose a major clinical challenge due to relapse, resistance, and limited durability of DNA-damaging therapies. This study identifies the glutaminyl-tRNA synthetase QARS as a key regulator of DNA damage response (DDR), showing translational control by MAPK signaling and an unexpected translation-independent mechanism for controlling homologous recombination (HR). QARS localizes to the nucleus, accumulates on chromatin after DNA damage, and promotes HR by interacting with SP100 within PML-nuclear bodies, enhancing recruitment of MRE11 and supporting repair efficiency in HGSOC models and patient-derived data.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/nuclear-localization-of-the-glutaminyl-trna-synthetase-qars-reveals-its-role-in-dna-damage-response-in-ovarian-cancer-abstract/352163/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/nuclear-localization-of-the-glutaminyl-trna-synthetase-qars-reveals-its-role-in-dna-damage-response-in-ovarian-cancer-abstract/352163.png","ImageObject",300,407,{"name":92,"@type":93},"CatatanPagi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does QARS play in DNA damage response of HGSOC?","Question",{"text":112,"@type":113},"QARS is demonstrated as a key player in DDR, promoting DNA repair through the homologous recombination (HR) pathway in ovarian cancer models and patient cohort analyses.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is QARS regulated in high-grade serous ovarian cancers?",{"text":117,"@type":113},"In HGSOC, QARS is regulated at the translational level by the MAPK pathway, linking signaling activity to DDR control.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism allows nuclear QARS to enhance HR after DNA damage?",{"text":121,"@type":113},"Nuclear QARS is enriched at chromatin upon DNA damage and enhances HR by interacting with the nuclear autoantigen SP100, a component of PML-nuclear bodies (PML-NB), supporting repair protein regulation including MRE11.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352163,1790158903,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},962090894170,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Article [https://doi.org/10.1038/s41467-026-76046-w](https://doi.org/10.1038/s41467-026-76046-w)  \nNuclear localization of the glutaminyl-tRNA synthetase QARS reveals its role in DNA damage response in ovarian cancer  \nReceived: 8 October 2025  \n\n| Accepted: 17 July 2026 |\n| --- |\n| |\n| Check for updates |\n\nMartina Seraﬁni1,2, Francesca Di Fazio1,2,3,10, Yann Kieffer 1,2,10,  \nLounes Djerroudi 1,2,4, Léonie Dec 5, Michael Richard 5, Yann Aubert 6  \n,  \nFranco Marchesoni-Acland7, Manuel D. Diaz-Munoz 6,  \nAnne Vincent-Salomon 1,2,4, Stéphan Vagner 8, Damarys Loew 5, Raphael Ceccaldi 2,9, Fatima Mechta-Grigoriou 1,2,11  & Virginie Mieulet 1,2,6,11   \nUncovering novel mechanisms controlling DNA damage response (DDR) is essential to better understand the molecular features of high-grade serous ovarian cancers (HGSOC), which remain a clinical challenge. Here, we demonstrate that the glutaminyl-tRNA-synthetase QARS is a key player in DDR. We show that QARS is regulated at translational level by the MAPK pathway in HGSOC and controls homologous recombination (HR) through a translationindependent mechanism. Analyses combining RNA sequencing, immunohistochemistry, proteomic data and functional assays from HGSOC patient cohorts and relevant cellular models reveal that QARS promotes DNA repair via the HR pathway. Interestingly, we uncover that QARS is located in the nucleus and is enriched at chromatin upon DNA damage. Nuclear QARS controls HR by interacting with the nuclear autoantigen SP100, a major component of PML-nuclear bodies (PML-NB), that are regulatory hubs for DNA repair proteins. Our data highlight nuclear functions and mechanisms for QARS involving SP100, PML-NB and MRE11 that enhance HR in HGSOC.  \nHigh-Grade Serous Ovarian Cancers (HGSOC) remain one of the deadliest gynecologic malignancies. First line treatments include DNA damaging agents such as platinum salts and taxane-based therapies. However, after initial response, most patients relapse, become resistant and die from the disease. Multi-omic approaches have led to the identiﬁcation of distinct molecular entities, highlighting the potential beneﬁt of targeted therapies1–6. Genomic  \nstudies identiﬁed several robust signatures of homologous recombination deﬁciency (HRD)3,7,8. HRD refers to the loss of function in the homologous recombination (HR) pathway, a high-ﬁdelity DNA repair mechanism that resolves double-strand breaks (DSBs) without loss of genetic information9. Approximately 50% of HGSOC tumors are HRD, due to genetic or epigenetic alterations in key components of the HR pathway, such as BRCA1 whose promoter is hypermethylated9. HRD is  \n1Stress and Cancer Laboratory, Equipe labélisée par la Ligue Nationale contre le Cancer, Institut Curie, PSL Research University, 26, rue d’Ulm, Paris, France. 2Inserm U1339, CNRS UMR3666, 26 rue d’Ulm, Paris, France. 3Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. 4Institut Curie, Department of Diagnostic and Theranostic Medicine, PSL Research University, 26, rue d’Ulm, Paris, France. 5Institut Curie, PSL Research University, CurieCoreTech Mass Spectrometry Proteomics, Paris, France. 6University of Toulouse, Toulouse Institute for Infectious and Inﬂammatory Diseases (INFINITy), Inserm UMR1291, CNRS UMR5051, CHU Purpan, Toulouse, France. 7Université Paris-Saclay, ENS Paris-Saclay, CNRS UMR9010, Centre Borelli, Gif-surYvette, France. 8Institut Curie, PSL Research University, CNRS UMR3348, Inserm, Orsay, France. 9Alternative DNA repair mechanisms in human cancers, Institut Curie, PSL Research University, 26, rue d’Ulm, Paris, France. 10These authors contributed equally: Francesca Di Fazio, Yann Kieffer. 11These authors jointly supervised this work: Fatima Mechta-Grigoriou,[Virginie Mieulet.](Virginie Mieulet. fatima.mechta-grigoriou@curie.fr)[ fatima.mechta-grigoriou@curie.fr](Virginie Mieulet. fatima.mechta-grigoriou@curie.fr); [virginie.mieulet@inserm.fr](virginie.mieulet@inserm.fr)  \na strong pred","cbCairnB924EnuGi","https://ap.wps.com/l/cbCairnB924EnuGi","pdf",6760678,24,"English","# Nuclear localization of QARS and DDR in HGSOC\n## QARS regulation by MAPK signaling\n## QARS promotes homologous recombination via SP100 and PML-NB","[{\"question\":\"What role does QARS play in DNA damage response of HGSOC?\",\"answer\":\"QARS is demonstrated as a key player in DDR, promoting DNA repair through the homologous recombination (HR) pathway in ovarian cancer models and patient cohort analyses.\"},{\"question\":\"How is QARS regulated in high-grade serous ovarian cancers?\",\"answer\":\"In HGSOC, QARS is regulated at the translational level by the MAPK pathway, linking signaling activity to DDR control.\"},{\"question\":\"What mechanism allows nuclear QARS to enhance HR after DNA damage?\",\"answer\":\"Nuclear QARS is enriched at chromatin upon DNA damage and enhances HR by interacting with the nuclear autoantigen SP100, a component of PML-nuclear bodies (PML-NB), supporting repair protein regulation including MRE11.\"}]","Nuclear localization of the glutaminyl-tRNA synthetase QARS reveals its role in DNA damage response in ovarian cancer - Abstract | PDF",1790098028,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e7ca7ae17a06c373679eccdb1bb4aba6.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0fd691b0edbaaba7da1f190050b4344f.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f33e2366513c57bac03688abbc13bb3b.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e51eb4e67bb163e85d1bd6f00e0a07b6.webp",980,1301]